AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34406619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2856
Study 32498932 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered intervention including the cumulative-complexity model
Number of subjects: 44
Study 32498932 — intervention group
Group type: COMPARATOR
Intervention: Control group (leaflet with information)
Number of subjects: 44
Study 33236105 — intervention group
Group type: EXPERIMENTAL
Intervention: RenalGuard® (RG) system
Number of subjects: 220
Study 33236105 — intervention group
Group type: COMPARATOR
Intervention: Current practice (control)
Number of subjects: 220
Study 35689272 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of rifapentine and isoniazid (3HP)
Number of subjects: 3000
Study 35689272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study 34658706 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling alone (MN)
Number of subjects: 120
Study 34658706 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical peeling alone (CP)
Number of subjects: 120
Study 34658706 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of microneedling and chemical peeling (MN + CP)
Number of subjects: 120
Study 35129994 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting distress intolerance (DI)
Number of subjects: 60
Study 35129994 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 60
Study 35129994 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress enhancement of the cannabis LPP
Number of subjects: 60
Study 33887209 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose (1.3 µg) plus AF03
Number of subjects: 441
Study 33887209 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose (1.3 µg) plus AS03
Number of subjects: 441
Study 33887209 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (2.6 µg) plus AF03
Number of subjects: 441
Study 33887209 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (2.6 µg) plus AS03
Number of subjects: 441
Study 33887209 — intervention group
Group type: EXPERIMENTAL
Intervention: Unadjuvanted high-dose (2.6 µg)
Number of subjects: 441
Study 33887209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study 32050996 — intervention group
Group type: EXPERIMENTAL
Intervention: Health star rating
Number of subjects: 2008
Study 32050996 — intervention group
Group type: COMPARATOR
Intervention: Control (NFt)
Number of subjects: 2008
Study 32050996 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic light
Number of subjects: 2008
Study 32050996 — intervention group
Group type: EXPERIMENTAL
Intervention: 'High-in' warning labels
Number of subjects: 2008
Study 36344308 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-guided slow breathing (SDB)
Number of subjects: 17
Study 36344308 — intervention group
Group type: COMPARATOR
Intervention: Sham control breathing
Number of subjects: 17
Study 33651033 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic cleaning in distilled water (Group B)
Number of subjects: 24
Study 33651033 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic bath with a special detergent solution (Group C)
Number of subjects: 24
Study 33651033 — intervention group
Group type: COMPARATOR
Intervention: No additional cleaning (Group A)
Number of subjects: 24
Study 32227771 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Jiedu decoction (YHJD)
Number of subjects: 330
Study 32227771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire with 30 items
Number of subjects: 151
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire with 60 items
Number of subjects: 151
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Three assessments per day
Number of subjects: 151
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Six assessments per day
Number of subjects: 151
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Nine assessments per day
Number of subjects: 151
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience Sampling Method (ESM)
Number of subjects: 151
Study 36174163 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 151
Study 34137526 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg twice a day
Number of subjects: 240
Study 34137526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 34767495 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 326
Study 34767495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 32918964 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolution of macular edema (ME)
Number of subjects: 177
Study 32918964 — intervention group
Group type: EXPERIMENTAL
Intervention: Epiretinal membranes on OCT
Number of subjects: 177
Study 32918964 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolved ME
Number of subjects: 177
Study 32918964 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes that did not resolve ME
Number of subjects: 177
Study 32918964 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes that developed ME during the year (incident or relapsed)
Number of subjects: 177
Study 34549258 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg enalapril and 0.8 mg folic acid
Number of subjects: 20702
Study 34549258 — intervention group
Group type: COMPARATOR
Intervention: 10 mg enalapril alone
Number of subjects: 20702
Study 32690472 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA treatment (2,152 mg of DHA per day)
Number of subjects: 33
Study 32690472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 36222597 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly semaglutide
Number of subjects: 0
Study 34470656 — intervention group
Group type: EXPERIMENTAL
Intervention: DICA Br supplemented with 30 g/day of mixed nuts (10 g of peanuts, 10 g of cashew, 10 g of Brazil nuts)
Number of subjects: 388
Study 34470656 — intervention group
Group type: COMPARATOR
Intervention: Only DICA Br
Number of subjects: 388
Study 34470656 — intervention group
Group type: EXPERIMENTAL
Intervention: DICA Br supplemented with mixed nuts
Number of subjects: 388
Study 33181580 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (5-15 mg)
Number of subjects: 47
Study 33181580 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (30-150 mg)
Number of subjects: 47
Study 33181580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 32071919 — intervention group
Group type: EXPERIMENTAL
Intervention: Micrografts containing human hair follicle mesenchymal stem cells (HF‐MSCs)
Number of subjects: 27
Study 32071919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 34687483 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine solution
Number of subjects: 116
Study 34687483 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine solution
Number of subjects: 116
Study 34687483 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 116
Study 32059924 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE)
Number of subjects: 82
Study 32059924 — intervention group
Group type: COMPARATOR
Intervention: Relapse Prevention Therapy (RPT)
Number of subjects: 82
Study 35552156 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification technique
Number of subjects: 15
Study 35552156 — intervention group
Group type: COMPARATOR
Intervention: Case Based Learning (CBL)
Number of subjects: 15
Study 33196289 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin bath therapy
Number of subjects: 60
Study 33196289 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine skin care program only)
Number of subjects: 60
Study 33878065 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochromic contact lens (activated)
Number of subjects: 54
Study 33878065 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochromic contact lens (inactivated)
Number of subjects: 54
Study 33878065 — intervention group
Group type: COMPARATOR
Intervention: Nonphotochromic contact lens (control)
Number of subjects: 54
Study 32045025 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP) intervention
Number of subjects: 483
Study 32045025 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 483
Study 35410312 — intervention group
Group type: EXPERIMENTAL
Intervention: TASC intervention (telehealth-enabled multidisciplinary stroke care)
Number of subjects: 50
Study 35410312 — intervention group
Group type: COMPARATOR
Intervention: Usual care (primary care nurse practitioner and stroke neurologist visits)
Number of subjects: 50
Study 32164653 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual Care (UC)
Number of subjects: 170
Study 32164653 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model with kinesiophobia
Number of subjects: 170
Study 32164653 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model without kinesiophobia
Number of subjects: 170
Study 36214072 — intervention group
Group type: EXPERIMENTAL
Intervention: QIVc
Number of subjects: 1667
Study 36214072 — intervention group
Group type: COMPARATOR
Intervention: QIV
Number of subjects: 1667
Study 35096742 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS) based on independent prognostic factors (age, race, T stage, histological grade, surgery, radiotherapy, chemotherapy)
Number of subjects: 1985
Study 35096742 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 1985
Study 35096742 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram-related decision curve analysis (DCA)
Number of subjects: 1985
Study 35096742 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk stratification using nomogram
Number of subjects: 1985
Study 36420360 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 20
Study 36420360 — intervention group
Group type: COMPARATOR
Intervention: Sham spinal manipulative therapy (sham SMT)
Number of subjects: 20
Study 32045673 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg with 9 g charcoal (charcoal-block condition)
Number of subjects: 72
Study 32045673 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg without charcoal (non-block condition)
Number of subjects: 72
Study 35806853 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Load Resistance Exercise (HL-RE) combined with Aerobic Exercise (AE)
Number of subjects: 79
Study 35806853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Load Resistance Exercise (LL-RE) combined with Aerobic Exercise (AE)
Number of subjects: 79
Study 35806853 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Exercise (AE)
Number of subjects: 79
Study 35806853 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Load Resistance Exercise (HL-RE)
Number of subjects: 79
Study 35806853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Load Resistance Exercise (LL-RE)
Number of subjects: 79
Study 35187850 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVE-PC
Number of subjects: 224
Study 35187850 — intervention group
Group type: COMPARATOR
Intervention: ABVD
Number of subjects: 224
Study 34536984 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher agency scores
Number of subjects: 131
Study 34536984 — intervention group
Group type: EXPERIMENTAL
Intervention: Action component of agency
Number of subjects: 131
Study 32708971 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridging therapy with r-tPA (bolus, partial dose, or full dose)
Number of subjects: 103
Study 32708971 — intervention group
Group type: COMPARATOR
Intervention: Direct MTE
Number of subjects: 103
Study 32708971 — intervention group
Group type: EXPERIMENTAL
Intervention: Full r-tPA dose
Number of subjects: 103
Study 36363493 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cold flow (CCF) therapy
Number of subjects: 100
Study 36363493 — intervention group
Group type: COMPARATOR
Intervention: Cold pack (gel ice)
Number of subjects: 100
Study 35199220 — intervention group
Group type: EXPERIMENTAL
Intervention: POD3/2 CRP
Number of subjects: 344
Study 35199220 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 25 kg/m2
Number of subjects: 344
Study 35199220 — intervention group
Group type: EXPERIMENTAL
Intervention: POD3/2 CRP > 1
Number of subjects: 344
Study 34116715 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 therapy
Number of subjects: 60
Study 34116715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34940781 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Bevacizumab
Number of subjects: 915
Study 34940781 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 915
Study 34643353 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous supportive telephone counselling for 14 days after neonatal discharge
Number of subjects: 65
Study 34643353 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 65
Study 32446164 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) treatment including levetiracetam (LEV), valproic acid (VA), and carbamazepine.
Number of subjects: 90
Study 32446164 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy participants).
Number of subjects: 90
Study 34688577 — intervention group
Group type: EXPERIMENTAL
Intervention: SLBs + FC
Number of subjects: 57
Study 34688577 — intervention group
Group type: EXPERIMENTAL
Intervention: SLBs
Number of subjects: 57
Study 34688577 — intervention group
Group type: COMPARATOR
Intervention: CBs
Number of subjects: 57
Study 32687541 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 247
Study 32687541 — intervention group
Group type: COMPARATOR
Intervention: Moderate or low physical activity
Number of subjects: 247
Study 32687541 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged standing
Number of subjects: 247
Study 32687541 — intervention group
Group type: EXPERIMENTAL
Intervention: Squatting
Number of subjects: 247
Study 34387827 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishen Taohong Granule (QTG)
Number of subjects: 76
Study 34387827 — intervention group
Group type: COMPARATOR
Intervention: Trimethazidine (TMZ)
Number of subjects: 76
Study 33899292 — intervention group
Group type: EXPERIMENTAL
Intervention: delta-tocotrienol (δT3) supplementation 250 mg once daily for 24 weeks
Number of subjects: 110
Study 33899292 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose soft gel capsule)
Number of subjects: 110
Study 35832135 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative planning (accurate unilateral puncture paths planned by preoperative CT data)
Number of subjects: 300
Study 35832135 — intervention group
Group type: COMPARATOR
Intervention: Conventional planning (multiple puncture procedures)
Number of subjects: 300
Study 33903144 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit Sense (usual care plus Quit Sense)
Number of subjects: 200
Study 33903144 — intervention group
Group type: COMPARATOR
Intervention: Usual care (referral to the NHS SmokeFree website)
Number of subjects: 200
Study 33276322 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 8
Study 33276322 — intervention group
Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 8
Study 32237995 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school physical activity club 3 d/wk
Number of subjects: 1194
Study 32237995 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school physical activity club 1 d/wk
Number of subjects: 1194
Study 32237995 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school physical activity club 2 d/wk
Number of subjects: 1194
Study 32237995 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1194
Study 33381204 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulative acupuncture (acupoints acupuncture combined with manipulations of twirling, lifting, and thrusting treatments)
Number of subjects: 120
Study 33381204 — intervention group
Group type: COMPARATOR
Intervention: Simple acupuncture (acupoints acupuncture therapy alone)
Number of subjects: 120
Study 33381204 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulative acupuncture
Number of subjects: 120
Study 33381204 — intervention group
Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 120
Study 35452377 — intervention group
Group type: COMPARATOR
Intervention: Didactic intervention
Number of subjects: 117
Study 35452377 — intervention group
Group type: COMPARATOR
Intervention: Perspective-taking intervention
Number of subjects: 117
Study 35452377 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 33495217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 277
Study 33495217 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine (ASMQ)
Number of subjects: 277
Study 33495217 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL+)
Number of subjects: 277
Study 33495217 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 277
Study 35180154 — intervention group
Group type: EXPERIMENTAL
Intervention: Test set (OCT scan moved inferotemporally)
Number of subjects: 84
Study 35180154 — intervention group
Group type: COMPARATOR
Intervention: Control set (no manipulation)
Number of subjects: 84
Study 34764687 — intervention group
Group type: EXPERIMENTAL
Intervention: TLIP block with general anesthesia
Number of subjects: 60
Study 34764687 — intervention group
Group type: COMPARATOR
Intervention: Control group (general anesthesia alone)
Number of subjects: 60
Study 35250820 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted neurorehabilitation using ARAMIS
Number of subjects: 118
Study 35250820 — intervention group
Group type: COMPARATOR
Intervention: Conventional neurorehabilitation
Number of subjects: 118
Study 34187737 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous lumbar transfacet screw placement with the Facet-Link ® system
Number of subjects: 46
Study 34187737 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative complication
Number of subjects: 46
Study 34187737 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiographic pseudarthrosis
Number of subjects: 46
Study 34187737 — intervention group
Group type: COMPARATOR
Intervention: Additional surgery
Number of subjects: 46
Study 34071868 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-ingredient pre-workout supplement (MIPS)
Number of subjects: 11
Study 34071868 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 11
Study 34615636 — intervention group
Group type: EXPERIMENTAL
Intervention: Obinutuzumab 1000 mg
Number of subjects: 125
Study 34615636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 33308975 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives ($1.50 for each day the goal was met, with a 20% chance of a $100 reward if the goal was met on >75% of the first 30 postoperative days)
Number of subjects: 33
Study 33308975 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 33
Study 33308975 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 33
Study 35928498 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet group (DG)
Number of subjects: 1125
Study 35928498 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity plus Diet group (PADG)
Number of subjects: 1125
Study 35928498 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity group (PAG)
Number of subjects: 1125
Study 35928498 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 1125
Study 35672832 — intervention group
Group type: EXPERIMENTAL
Intervention: E-HELD intervention (therapist-guided Internet-based cognitive-behavioral therapy)
Number of subjects: 130
Study 35672832 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 130
Study 35672832 — intervention group
Group type: EXPERIMENTAL
Intervention: E-HELD intervention
Number of subjects: 130
Study 32152326 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 (2.5 g/L foliar application twice at nursery with a one‐week interval)
Number of subjects: 0
Study 32152326 — intervention group
Group type: COMPARATOR
Intervention: T0 (control)
Number of subjects: 0
Study 32646228 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 34
Study 32646228 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study 35798020 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g prunes
Number of subjects: 235
Study 35798020 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g prunes
Number of subjects: 235
Study 35798020 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 235
Study 34173295 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramsay scale
Number of subjects: 65
Study 32748463 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS-TBNA
Number of subjects: 100
Study 32748463 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-B-FNA
Number of subjects: 100
Study 35729217 — intervention group
Group type: EXPERIMENTAL
Intervention: More time spent in clinical hypoglycemia (defined by median split)
Number of subjects: 211
Study 33739437 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (12 weeks, twice weekly)
Number of subjects: 28
Study 33739437 — intervention group
Group type: COMPARATOR
Intervention: Control group (continuation of usual lifestyle)
Number of subjects: 28
Study 36470964 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 150
Study 36470964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 33479274 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics administered in the first 48 hours after birth
Number of subjects: 91